【银诺克是哪个国家的品牌？】

长春银诺克药业有限公司简称银诺克药业，总部位于吉林省长春市经济技术开发区生物园区，是集科研、销售和生产为一体的综合性现代化制药企业。

银诺克药业在发展中，培育了以“合作，创新，使命，竞争”企业精神为核心的企业文化，奠定了企业可持续发展的基础；一直以来，始终坚持“质量第一，信誉至上，让每一个外部、内部客户满意”的服务宗旨，积极开发营销网络，产品遍布全国各地。“银诺克”连续几年被评为吉林省著名商标；长春银诺克药业有限公司于2004年11月、2008年12月两次被吉林省科学技术厅认定为“高新技术企业”；2007年长春银诺克药业有限公司被吉林省专利局评定为“专利示范企业”。

“逆水行舟，不进则退”，激烈的市场竞争要求企业不断推陈出新，2004年成立的银诺克药物研究所担负着“产品研发一代，储备一代，销售一代”的重任，企业发展后劲不断增强。银诺克集团现有13个剂型共200余个品种，独家新药4个，中药保护品种2个。在研品种80余个，其中独家新药品种6个，为更有力占领市场奠定了坚实的基础。

“重质量，重疗效，做百姓放心药”体现着企业的核心价值观，银诺克药业在向社会奉献百姓称道药品的同时，没有忘记企业的社会责任，始终关注和支持社会公益事业，积极参与赈灾救危等公益活动，用于各类捐赠累计价值达千万元，以实际行动回馈了社会。面向未来，银诺克人将秉承“自立自强，不断进取，以人类健康为己任”的企业理念，为人类健康事业不断做出新的更大的贡献。

英文翻译：Changchun yinnock Pharmaceutical Co., Ltd. is referred to as yinnock pharmaceutical, headquartered in the biological park of Changchun Economic and Technological Development Zone, Jilin Province. It is a comprehensive modern pharmaceutical enterprise integrating scientific research, sales and production. In the development of yinnock pharmaceutical, it has cultivated the corporate culture with the corporate spirit of "cooperation, innovation, mission and competition" as the core, and laid the foundation for the sustainable development of the enterprise. It has always adhered to the service tenet of "quality first, reputation first, and satisfaction of every external and internal customer", and actively developed the marketing network, with products all over the country. "Yinnock" has been rated as a famous trademark of Jilin Province for several consecutive years; Changchun yinnock Pharmaceutical Co., Ltd. was recognized as "high and new technology enterprise" by Jilin Science and technology department twice in November 2004 and December 2008; Changchun yinnock Pharmaceutical Co., Ltd. was rated as "patent demonstration enterprise" by Jilin Patent Office in 2007. "Sailing against the current, if you don't advance, you will go back". The fierce market competition requires the enterprise to constantly push through the old and bring forth the new. The yinnuke Pharmaceutical Research Institute established in 2004 is responsible for the task of "product R & D generation, reserve generation, sales generation". The enterprise's development potential is constantly enhanced. Yinnock group has 13 dosage forms with more than 200 varieties, 4 exclusive new drugs and 2 traditional Chinese medicine protection varieties. There are more than 80 varieties under research, including 6 exclusive new drug varieties, which have laid a solid foundation for occupying the market more effectively. "Focus on quality, focus on curative effect, and be a reassuring drug for the common people" embodies the core values of the enterprise. Yinnock pharmaceutical industry, while offering the common people praise drugs, has not forgotten the social responsibility of the enterprise, has always paid attention to and supported social public welfare undertakings, actively participated in public welfare activities such as disaster relief and rescue, and has used various donations with a cumulative value of tens of millions of yuan, and has given back to the society with practical actions. Facing the future, yinnock people will adhere to the enterprise philosophy of "self-reliance, continuous progress, and human health as their own responsibility", and make new and greater contributions to the cause of human health.

本文链接： https://www.waitui.com/brand/e92f6c7c3.html 联系电话：0431-82811229